SCHEMBL907869

SCHEMBL907869

CC1CC(N)=NN1c1cccc(F)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PRKCZ Q05513 1/20 0.45
▸ ALOX5 P09917 1/20 0.42
▸ C1S P09871 3/20 0.38
▸ BPTF Q12830 1/20 0.38
▸ PI4KA P42356 1/20 0.37
▸ PI4K2B Q8TCG2 1/20 0.37
▸ PI4K2A Q9BTU6 1/20 0.37
▸ PI4KB Q9UBF8 1/20 0.37
▸ KEAP1 Q14145 1/20 0.36
▸ FAAH O00519 1/20 0.36
▸ MGLL Q99685 1/20 0.36
▸ NOTUM Q6P988 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ FADS1 O60427 1/20 0.35
▸ DHFR P00374 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL908054 0.82 PRKCZ (0.45) PRKCZALOX5MEN1KMT2ADHFR
SCHEMBL907673 0.81 PRKCZ (0.43) PRKCZALOX5C1SBPTFPI4KA
SCHEMBL908100 0.81 ALOX5 (0.53) PRKCZALOX5NOTUMMEN1KMT2A
SCHEMBL7719321 0.81 PRKCZ (0.40) PRKCZMEN1KMT2AL3MBTL1DHFR
SCHEMBL7721905 0.80 L3MBTL1 (0.40) PRKCZALOX5MEN1KMT2AL3MBTL1
SCHEMBL907668 0.79 PRKCZ (0.43) PRKCZALOX5C1SBPTFPI4KA
SCHEMBL11095289 0.79 PRKCZ (0.52) PRKCZMEN1KMT2AL3MBTL1MAOA
SCHEMBL11068397 0.76 PRKCZ (0.52) PRKCZ
SCHEMBL7719322 0.74 ABL1 (0.58) L3MBTL1DHFR
Sulfuric Acid SCHEMBL11092651 0.74 PDE5A (0.45) PRKCZMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110003862-A1 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases MERCK SHARP & DOHME LIMITED (GB) 2011-01-06 — — US claimed
EP-1987007-A1 3-AMINOPYRAZOLINES FOR TREATMENT OF NEURODEGENERATIVE AND PSYCHIATRIC DISEASES MERCK SHARP & DOHME LTD. (GB) 2008-11-05 — — EP claimed
WO-2007093829-A1 3-AMINOPYRAZOLINES FOR TREATMENT OF NEURODEGENERATIVE AND PSYCHIATRIC DISEASES MERCK SHARP & DOHME LIMITED (GB) 2007-08-23 — — WO claimed
US-4451479-A ANTIINFLAMMATORY AMERICAN CYANAMID COMPANY (US) 1984-05-29 — — US claimed
US-20110003862-A1 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases MERCK SHARP & DOHME LIMITED (GB) 2011-01-06 — — US disclosed
EP-1987007-A1 3-AMINOPYRAZOLINES FOR TREATMENT OF NEURODEGENERATIVE AND PSYCHIATRIC DISEASES MERCK SHARP & DOHME LTD. (GB) 2008-11-05 — — EP disclosed
WO-2007093829-A1 3-AMINOPYRAZOLINES FOR TREATMENT OF NEURODEGENERATIVE AND PSYCHIATRIC DISEASES MERCK SHARP & DOHME LIMITED (GB) 2007-08-23 — — WO disclosed
US-4451479-A ANTIINFLAMMATORY AMERICAN CYANAMID COMPANY (US) 1984-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003862-A1 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases DAO, DDO, MAOA PRKCZ 2127/4885ALOX5 1140/4885C1S 4628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback